Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies

INTRODUCTION: Treatment of neovascular age-related macular degeneration (nAMD) has evolved with the advent of anti-vascular endothelial growth factor agents such that intravitreally administered aflibercept and ranibizumab (RBZ) have become the standard of care. Randomized clinical trials (RCTs) hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrasco, Joao, Pietsch, Georg-Alexander, Nicolas, Marie-Pierre, Koerber, Cecile, Bennison, Craig, Yoon, Jisu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979459/
https://www.ncbi.nlm.nih.gov/pubmed/31728825
http://dx.doi.org/10.1007/s12325-019-01147-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979459/
https://www.ncbi.nlm.nih.gov/pubmed/31728825
http://dx.doi.org/10.1007/s12325-019-01147-6

Ejemplares similares